Houston-based Proxima Clinical Research has expanded its footprint thanks to a recent partnership. Image via proximacro.com

Houston-based Proxima Clinical Research announced this month that it will expand its clinical trial offerings by adding NEXT Oncology to its Early Phase Oncology Network, or EPON.

NEXT Oncology is a Phase I clinical trial treatment center with locations in Austin, Dallas, San Antonio, and Virginia, as well as international locations in Barcelona and Madrid. These centers provide innovative and investigational treatments and therapies to patients with advanced forms of cancers.

The addition of NEXT Oncology's clinics brings Proxima's oncology network up to 14 physical locations and eight clinical practices, Robbin Frnka, executive director of clinical development and strategy at Proxima CRO tells InnovationMap.

“Early phase oncology trials are some of the most delicate and important trials to conduct, both from a science perspective and in offering hope for late-stage patients,” Dr. Anthony Tolcher, CEO and founder of NEXT Oncology, says in a statement. “We proudly designed NEXT Oncology specifically to bring the best new agents to patients through our specially designed centers located around the world. This new relationship with Proxima CRO’s EPON will help us further enhance our mission and contribute to our life’s work of advancing cancer treatments to save more lives from cancer around the world.”

Proxima is a Houston-based contract research organization focused on supporting life science startups as they grow and scale. It was recently named to the the Inc. 5000 regional rankings for the Southwest for its fast-growing revenue.

The company launched its EPON in March to support Phase I and Phase II clinical oncology trials and a group of oncology-specific scientific experts. The Mary Crowley Cancer Research, a specialized clinical research center in Dallas, was one of the first to join the network.

"Finding the right clinical sites and investigators with the right patients is one of the biggest struggles of early phase clinical trials," Frnka says in a March statement. "Our Early Phase Oncology Network, which we're calling EPON, includes some of the most prominent investigators in early phase trials. Receiving expert feedback, insight, and guidance from this skilled scientific panel is critical to the success of these earliest phase trials."

In addition to work in the cancer field, Proxima also launched its M1 MedTech accelerator last year aimed at helping startups quickly grow their health tech businesses. Its inaugural cohort included startups with new tech and treatments for heart arrhythmias, ultrasounds, bioelectric implants in the body and more.

The company also recently expanded its footprint within the Texas Medical Center Innovation Factory.

InnovationMap spoke with Proxima CEO and Co-founder Kevin Coker on the Houston Innovators Podcast.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston university lands $2.5M grant for STEM inclusivity

DEI in STEM

Rice University was recently granted $2.5 million to develop programs that make STEM degrees more accessible to students of all walks of life.

The five-year grant is part of The Howard Hughes Medical Institute's Driving Change initiative, which focuses on breaking down barriers in STEM fields at research universities.

Rice is one of six universities to receive the grant this year. According to a statement from Rice, this year's winners were named for making "culture change efforts" within the universities.

“Rice has laid the groundwork for student success, and this funding will allow us to teach math courses in an accessible way that is inclusive to all students and promotes equity in STEM," Amy Dittmar, Howard R. Hughes Provost and executive vice president for academic affairs, says in a statement. "Students who are underrepresented, first-generation college students, Pell grant recipients, women and athletes should have the same opportunities for success as everyone else.”

Other universities in the 2023 cohort include:

  • The University of California, Los Angeles
  • Illinois State University
  • The University of Massachusetts, Amherst
  • Rice University
  • Rutgers University – Camden
  • The University of Vermont

The first group of six universities awarded a Driving Change grant were named last year. Awardees are also part of the HHMI Driving Change Learning Community of 38 institutions that aim to create more inclusive environments.

“Each of this year’s grantee institutions has demonstrated their dedication to carrying out critical, intensive work for the betterment of the wider world of STEM and STEM education,” Sarah Simmons, HHMI program lead for Driving Change, says in a statement. “Part of this work includes a thorough self-study to ensure that each institution identifies its own unique needs. We are honored to be a part of a community with so many change-makers who are driven by the goal of making science and science education accessible to everyone.”

The grant was secured by Rice team members Janet Braam, Margaret Beier, Alex Byrd, Liz Eich, Dereth Phillips, Caroline Quenemoen, Renata Ramos, Matt Taylor and Tony Varilly Alvarado.

Earlier this fall, Rice also announced the Liu Idea Lab for Innovation and Entrepreneurship, or Lilie, which recruited 11 entrepreneurs to the council with Houston ties to support “promising entrepreneurial programs for students, research staff and faculty.” Each has agreed to donate time and money to the university’s entrepreneurship programs.

That same month, Rice teamed up with Houston Methodist to open the new Center for Human Performance.

Prominent Houston energy business leader to retire, successor named

in transition

Amy Chronis, a Houston business leader within the energy industry and beyond, is retiring next summer. Her replacement has been named.

Melinda Yee will be the incoming Houston managing partner at Deloitte, replacing Chronis who held the role along with the title vice chair and US energy and chemicals leader. Chronis will retire in June 2024, and Yee's new role is effective January 2.

“Melinda has been an active and valued member of Deloitte’s Houston leadership team. She brings an impressive depth of both industry and marketplace knowledge to her new role as managing partner,” Chronis says in a news release. “I am confident that she will be a great leader for our Houston professionals and in the local community.”

Yee has worked at Deloitte for over 30 years and has served as both Deloitte’s central region risk and advisory leader as well as the Houston risk and advisory leader. She also held the title of energy and chemicals leader within Deloitte’s mergers, acquisitions, and restructuring services practice. She's worked on transactions across the energy value chain, as well as waste management, manufacturing, industrials, services, retail operations and investment management, per the release.

“I am honored to have been asked to serve as the managing partner for Deloitte’s Houston practice,” Yee says in the release. “I look forward to continuing the great work Deloitte has accomplished under Amy’s leadership, delivering results for our clients and making an impact in the Houston community.”

In addition to her role at Deloitte, she serves as a board member for Junior Achievement of Southeast Texas, a member of the Energy Transition Committee for the Greater Houston Partnership, and is Audit Committee chair, director and trustee at the University of Colorado Foundation.

------

This article originally ran on EnergyCapital.